JP2023538419A5 - - Google Patents
Info
- Publication number
- JP2023538419A5 JP2023538419A5 JP2023512647A JP2023512647A JP2023538419A5 JP 2023538419 A5 JP2023538419 A5 JP 2023538419A5 JP 2023512647 A JP2023512647 A JP 2023512647A JP 2023512647 A JP2023512647 A JP 2023512647A JP 2023538419 A5 JP2023538419 A5 JP 2023538419A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- composition according
- administered
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382764.7 | 2020-08-21 | ||
| EP20382764.7A EP3957308A1 (en) | 2020-08-21 | 2020-08-21 | (1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid and derivatives thereof for use in the treatment of airway diseases |
| PCT/EP2021/073133 WO2022038261A1 (en) | 2020-08-21 | 2021-08-20 | (1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid and derivatives thereof for use in the treatment of airway diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023538419A JP2023538419A (ja) | 2023-09-07 |
| JP2023538419A5 true JP2023538419A5 (enExample) | 2024-07-29 |
| JP7794807B2 JP7794807B2 (ja) | 2026-01-06 |
Family
ID=72234795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512647A Active JP7794807B2 (ja) | 2020-08-21 | 2021-08-20 | 気道疾患の治療に使用するための（１ｒ，３ｓ）－３－（（５－シアノ－４－フェニルチアゾール－２－イル）カルバモイル）シクロペンタン－１－カルボン酸およびその誘導体 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20230321053A1 (enExample) |
| EP (2) | EP3957308A1 (enExample) |
| JP (1) | JP7794807B2 (enExample) |
| KR (1) | KR20230054444A (enExample) |
| CN (1) | CN115942933A (enExample) |
| AU (1) | AU2021327728A1 (enExample) |
| BR (1) | BR112023002778A2 (enExample) |
| CA (1) | CA3190081A1 (enExample) |
| DK (1) | DK4199922T3 (enExample) |
| ES (1) | ES3001104T3 (enExample) |
| FI (1) | FI4199922T3 (enExample) |
| HR (1) | HRP20241621T1 (enExample) |
| HU (1) | HUE069338T2 (enExample) |
| LT (1) | LT4199922T (enExample) |
| MX (1) | MX2023002156A (enExample) |
| PL (1) | PL4199922T3 (enExample) |
| PT (1) | PT4199922T (enExample) |
| RS (1) | RS66263B1 (enExample) |
| SI (1) | SI4199922T1 (enExample) |
| WO (1) | WO2022038261A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6871948B2 (ja) | 2016-04-27 | 2021-05-19 | アッヴィ・インコーポレイテッド | 抗ｉｌ−１３抗体を使用する、ｉｌ−１３活性が有害である疾患の治療方法 |
| IL308258A (en) | 2021-05-05 | 2024-01-01 | Immatics Biotechnologies Gmbh | Bma031 antigen binding polypeptides |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070219223A1 (en) * | 2006-03-07 | 2007-09-20 | Endacea, Inc. | Compositions and methods for treating respiratory disorders |
| ES2331220B1 (es) * | 2007-10-02 | 2010-09-23 | Palobiofarma, S.L. | Nuevos compuestos como antagonistas de los receptores a1 de adenosina. |
| WO2015057668A1 (en) * | 2013-10-15 | 2015-04-23 | Medimmune, Llc | Methods for treating chronic obstructive pulmonary disease using benralizumab |
| UA122670C2 (uk) * | 2014-09-08 | 2020-12-28 | Сефалон, Інк. | Спосіб лікування еозинофільної астми у пацієнта |
| ES2676535B1 (es) * | 2017-01-20 | 2019-04-29 | Palobiofarma Sl | Moduladores de los receptores a3 de adenosina |
| HRP20211104T1 (hr) * | 2017-03-06 | 2021-10-15 | Palobiofarma, S.L. | Aminska sol (1r,3s)-3-(5-cijano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksilne kiseline |
-
2020
- 2020-08-21 EP EP20382764.7A patent/EP3957308A1/en not_active Withdrawn
-
2021
- 2021-08-20 EP EP21765908.5A patent/EP4199922B1/en active Active
- 2021-08-20 SI SI202130242T patent/SI4199922T1/sl unknown
- 2021-08-20 AU AU2021327728A patent/AU2021327728A1/en active Pending
- 2021-08-20 CN CN202180051106.2A patent/CN115942933A/zh active Pending
- 2021-08-20 HR HRP20241621TT patent/HRP20241621T1/hr unknown
- 2021-08-20 PL PL21765908.5T patent/PL4199922T3/pl unknown
- 2021-08-20 LT LTEPPCT/EP2021/073133T patent/LT4199922T/lt unknown
- 2021-08-20 KR KR1020237009717A patent/KR20230054444A/ko active Pending
- 2021-08-20 US US18/040,508 patent/US20230321053A1/en active Pending
- 2021-08-20 HU HUE21765908A patent/HUE069338T2/hu unknown
- 2021-08-20 ES ES21765908T patent/ES3001104T3/es active Active
- 2021-08-20 MX MX2023002156A patent/MX2023002156A/es unknown
- 2021-08-20 FI FIEP21765908.5T patent/FI4199922T3/fi active
- 2021-08-20 DK DK21765908.5T patent/DK4199922T3/da active
- 2021-08-20 JP JP2023512647A patent/JP7794807B2/ja active Active
- 2021-08-20 RS RS20241285A patent/RS66263B1/sr unknown
- 2021-08-20 PT PT217659085T patent/PT4199922T/pt unknown
- 2021-08-20 WO PCT/EP2021/073133 patent/WO2022038261A1/en not_active Ceased
- 2021-08-20 CA CA3190081A patent/CA3190081A1/en active Pending
- 2021-08-20 BR BR112023002778A patent/BR112023002778A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5492072B2 (ja) | 喘息の増悪の予防および／または治療のためのフォルモテロールおよびジプロピオン酸ベクロメタゾンを含む組成物の使用 | |
| AU2020226339B2 (en) | Methods of treatment of respiratory disorders | |
| JP2023538419A5 (enExample) | ||
| CN106488770A (zh) | 用于治疗copd的福莫特罗和布地奈德的组合 | |
| FI4199922T3 (fi) | (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa | |
| JP5068912B2 (ja) | ロテプレドノールとβ２アドレナリン受容体アゴニストの新規組み合わせ | |
| US20190224164A1 (en) | Compositions and methods for treatment of copd | |
| US20020198228A1 (en) | Composition and method for the treatment of respiratory desease | |
| JP6021952B2 (ja) | 慢性閉塞性肺疾患の治療法 | |
| JP6188784B2 (ja) | 炎症性および免疫性疾患の治療のための組成物 | |
| JP2016504358A (ja) | オキシブチニンを投与するための方法および組成物 | |
| WO2026052051A1 (zh) | 杂环化合物在治疗肺疾病中的应用 | |
| NZ707754B2 (en) | Combination of glycopyrrolate and a beta2 -agonist |